top of page
Image by Heliberto Arias

2018 Annual Conference

Therapeutic Antibodies: Frontiers and Opportunities

April 29, 2018

Boston Marriott Cambridge

Speakers

SVP, BeiGene

Wendy Yan

SVP, BeiGene

General Manager, Livzon MabPharm

Daotian Fu

General Manager, Livzon MabPharm

 Chief Medical Officer
 Qilu Pharmaceuticals

Yong-jiang Hei

Chief Medical Officer
Qilu Pharmaceuticals

Professor of Pathology and Immunology, UT Southwestern Medical Center

Yang-Xin Fu

Professor of Pathology and Immunology, UT Southwestern Medical Center

CEO, Eureka Therapeutics Inc

Cheng Liu

CEO, Eureka Therapeutics Inc

Chair of Board of Directors, Chinese Antibody Society; Co-founder, CEO and President, Innovent Biologics

Michael Yu

Chair of Board of Directors, Chinese Antibody Society; Co-founder, CEO and President, Innovent Biologics

Director, Wuxi Biologics; President, Chinese Antibody Society

Shawn (Shouye) Wang

Director, Wuxi Biologics; President, Chinese Antibody Society

CEO, HengRui R&D Center

Weikang Tao

CEO, HengRui R&D Center

 Principal
 Fish & Richardson P.C.

Teresa A. Lavoie

Principal
Fish & Richardson P.C.

Board Director, Chair of Advisory Committee, 
Chinese Antibody Society; 
Sr. Investigator, NIH

Mitchell Ho

Board Director, Chair of Advisory Committee,
Chinese Antibody Society;
Sr. Investigator, NIH

CEO & President, Henlius Biopharmaceuticals

Scott Liu

CEO & President, Henlius Biopharmaceuticals

SVP and Head of Biologics Research and CMC, NGM Biopharmaceuticals

Wenyan (David) Shen

SVP and Head of Biologics Research and CMC, NGM Biopharmaceuticals

AVP, Sanofi; Chair of Conference Organizing Committee, Board Member

Fubao Wang

AVP, Sanofi; Chair of Conference Organizing Committee, Board Member

Founder and Owner, BioStro Biotech Consulting LLC

William R. Strohl

Founder and Owner, BioStro Biotech Consulting LLC

2018 Conference Sponsors.PNG
bottom of page